Status:
TERMINATED
Lcr35 / ICU / P. Aeruginosa
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Université d'Auvergne
Conditions:
Pseudomonas Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Preventing carriage of potentially pathogenic micro-organisms from the aerodigestive tract is an infection control strategy used to reduce the occurrence of nosocomial infections - including ventilato...
Detailed Description
In this prospective double-blind randomised study, ICU patients receive twice a day either an oral dose of Lactobacillus casei rhamnosus, the available pharmaceutical form, or a placebo. Digestive tra...
Eligibility Criteria
Inclusion
- more than 18 years old
- length of stay longer than 48h
- with a nasogastric feeding tube
Exclusion
- \- less than 18 years old
- length of stay \< 48h
- immunosuppression
- absolute neutrophile count \< 500/mm3
- gastro-intestinal bleeding
- contraindicated enteral feeding
- positive P. aeruginosa gastric aspirates or respiratory tract specimens during the first four days after hospital admission
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00621803
Start Date
March 1 2003
End Date
October 1 2005
Last Update
February 22 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.